Total parasite biomass but not peripheral parasitaemia is associated with endothelial and haematological perturbations in Plasmodium vivax patients

Autor: Kannan Venugopal, Matthias Marti, Fabio T. M. Costa, Dario Beraldi, Marcus Vg Lacerda, Stefanie C. P. Lopes, Carla C. Judice, Erich E.V. Paula, Diógenes S. de Lima, João Luiz Silva-Filho, João Conrado Khouri Dos-Santos, Helder I. Nakaya
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Male
Plasmodium vivax
endothelial activation
total biomass
Parasitemia
0302 clinical medicine
Parasite hosting
Biomass
Biology (General)
0303 health sciences
education.field_of_study
Microbiology and Infectious Disease
biology
malaria parasite
General Neuroscience
General Medicine
Middle Aged
3. Good health
Haematopoiesis
medicine.anatomical_structure
tissue infection
Cohort
Medicine
Female
Research Article
Human
Adult
QH301-705.5
Science
030231 tropical medicine
Population
Spleen
General Biochemistry
Genetics and Molecular Biology

Endothelial activation
03 medical and health sciences
Young Adult
parasitic diseases
medicine
Malaria
Vivax

Humans
education
030304 developmental biology
General Immunology and Microbiology
haematopoiesis
biology.organism_classification
medicine.disease
Immunology
Bone marrow
BIOMASSA
Malaria
Zdroj: eLife
eLife, Vol 10 (2021)
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
ISSN: 2050-084X
Popis: Plasmodium vivax is the major cause of human malaria in the Americas. How P. vivax infection can lead to poor clinical outcomes, despite low peripheral parasitaemia remains a matter of intense debate. Estimation of total P. vivax biomass based on circulating markers indicates existence of a predominant parasite population outside of circulation. In this study we investigate associations between both peripheral and total parasite biomass and host response in vivax malaria. We analysed parasite and host signatures in a cohort of uncomplicated vivax malaria patients from Manaus, Brazil, combining clinical and parasite parameters, multiplexed analysis of host responses and ex vivo assays. Patterns of clinical features, parasite burden and host signatures measured in plasma across the patient cohort were highly heterogenous. Further data deconvolution revealed two patient clusters, here termed Vivaxlow and Vivaxhigh. These patient subgroups were defined based on differences in total parasite biomass but not peripheral parasitaemia. Overall Vivaxlow patients clustered with healthy donors and Vivaxhigh patients showed more profound alterations in haematological parameters, endothelial cell (EC) activation and glycocalyx breakdown and levels of cytokines regulating different haematopoiesis pathways compared to Vivaxlow. Vivaxhigh patients presented more severe thrombocytopenia and lymphopenia, along with enrichment of neutrophils in the peripheral blood and increased neutrophil-to-lymphocyte ratio (NLCR). When patients’ signatures were combined, high association of total parasite biomass with a subset of markers of EC activation, thrombocytopenia and lymphopenia severity was observed. Finally, machine learning models defined a combination of host parameters measured in the circulation that could predict the extent of parasite infection outside of circulation. Altogether, our data show that total parasite biomass is a better predictor of perturbations in host homeostasis in P. vivax patients than peripheral parasitaemia. This supports the emerging paradigm of a P. vivax tissue reservoir, in particular in the hematopoietic niche of bone marrow and spleen.
Databáze: OpenAIRE